HR Execs on the Move


 
Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines that will meet serious unmet medical needs in oncology and other diseases. Incyte is a company driven by innovation, and we believe that investment in cutting-edge science and the rigorous pursuit of R&D excellence can translate into new medicines for serious unmet medical needs that positively impact patients` lives. Incyte has a diverse and growing portfolio of first-in-class and best-in-class product candidates, including both small and large molecules. Incyte is headquartered in Wilmington, Delaware with operations in 10 European countries and Japan. Our more than ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.incyte.com
  • 1801 Augustine Cut-off
    Wilmington, DE USA 19880
  • Phone: 855.446.2983

Executives

Name Title Contact Details
Bashir Ahmed
Senior Director, R&D IT - Clinical Profile
John Krukiel
Division Vice President US Product Strategy Profile
Marwan Sawaked
Senior Director, R&D GMP QA Profile
Vince Fasciocco
Head of R&D Finance Profile

Similar Companies

MindLinc: Duke University BHI

MindLinc: Duke University BHI is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Threshold Enterprises

Threshold Enterprises is a wholesale distributor of dietary supplements and health care products to the natural foods industry and health care professionals. We don't sell directly to consumers. If you want to open an account, or are a current customer

Aristea Therapeutics

Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases.

Heliospectra

Heliospectra is a world leader in intelligent LED grow lights for greenhouse cultivation and controlled environments horticulture. Our products are based on a deep knowledge of plant physiology and photosynthesis – as well as unique ways of utilizing modern LED technology.

iBio

iBio is an innovator biologics company developing therapeutics and vaccines for the betterment of human and animal health with pipeline candidates targeting systemic sceleroderma (IBIO-100), COVID-19 (IBIO-200 and IBIO-201), and classical swine fever (IBIO-400). iBio`s subsidiary, iBio CDMO is a global leader in plant-based manufacturing. It`s FastPharming® and FastGlycaneering™ platforms provide contract development and manufacturing services via its 130,000 square foot facility in Bryan, Texas. The speed and scalability of FastPharming make it an ideal choice for other innovator companies who want to rapidly produce biologics.